Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

11.5%

3 terminated/withdrawn out of 26 trials

Success Rate

81.3%

-5.3% vs industry average

Late-Stage Pipeline

15%

4 trials in Phase 3/4

Results Transparency

46%

6 of 13 completed trials have results

Key Signals

1 recruiting6 with results

Enrollment Performance

Analytics

Phase 1

6(40.0%)

N/A

3(20.0%)

Phase 3

2(13.3%)

Phase 4

2(13.3%)

Early Phase 1

1(6.7%)

Phase 2

1(6.7%)

15Total

Phase 1(6)

N/A(3)

Phase 3(2)

Phase 4(2)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (26)

Showing 20 of 26 trials

NCT07425496Recruiting

To Study Ocular Outflow Dynamics of the Eye Using Intraoperative Tonographic Biometry and Assess Its Predictive Value in Improving Postoperative Outcomes.

Role: lead

NCT04479761Not ApplicableCompleted

Sensory Integration of Auditory and Visual Cues in Diverse Contexts

Role: collaborator

NCT01551550Not ApplicableCompleted

Shunt Tube Exposure Prevention Study

Role: collaborator

NCT05324189Unknown

Automated AI-based System for Early Diagnosis of Diabetic Retinopathy

Role: lead

NCT04863391Unknown

Telemedicine in Age-Related Macular Degeneration

Role: lead

NCT02984813Phase 1Terminated

Safety and Efficacy of Anti-Oxidants and Anti-inflammatory Agents in Glaucoma and Diabetic Retinopathy

Role: lead

NCT02990143Phase 2Terminated

The Effectiveness of Ologen® Collagen Matrix in Preventing Intraocular Pressure (IOP) Spikes After Ahmed Glaucoma Valve Surgery (AGV-FP7)

Role: lead

NCT04087356Unknown

Age-related Macular Degeneration (AMD) and Cardiovascular Disease

Role: lead

NCT03918590Phase 4Unknown

Post Intravitreal Injection Topical NSAID vs. Patching

Role: lead

NCT01440751Phase 4Completed

Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery

Role: collaborator

NCT01590238Phase 3Completed

Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)

Role: lead

NCT00956020Phase 1Completed

Evaluation of the Mechanism of Action of Platelet Rich Fibrin Matrix (PRFM) in Producing Skin Volume Augmentation

Role: lead

NCT00201617Completed

Efficacy of the Bone-anchored Hearing Aid for Unilateral Deafness

Role: lead

NCT00570726Phase 1Completed

Treatment of Failing Blebs With Ranibizumab

Role: lead

NCT00803998Completed

Ocular Hypertension Treatment Study (OHTS)

Role: lead

NCT00846092Phase 1Completed

Near-infrared Light (NIR) Therapy for Diabetic Macular Edema: A Pilot Study

Role: collaborator

NCT00874094Phase 1Completed

Pilot Evaluation of Platelet Rich Fibrin Matrix (PRFM) for the Correction of Nasolabial Folds

Role: lead

NCT01846364Early Phase 1Terminated

DIM as a Treatment for Thyroid Disease

Role: lead

NCT00541333Phase 1Suspended

Weekly Vaccination With Copaxone as a Potential Therapy for Dry Age-related Macular Degeneration

Role: lead

NCT00347308Completed

Photographic Assessment of Eyebrow Position and Range of Motion

Role: lead